{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,19]],"date-time":"2026-06-19T18:52:37Z","timestamp":1781895157692,"version":"3.54.5"},"reference-count":187,"publisher":"MDPI AG","issue":"12","license":[{"start":{"date-parts":[[2023,11,24]],"date-time":"2023-11-24T00:00:00Z","timestamp":1700784000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Biomolecules"],"abstract":"<jats:p>Mesenchymal stromal cells (MSCs) are a subset of heterogeneous, non-hematopoietic fibroblast-like cells which play important roles in tissue repair, inflammation, and immune modulation. MSCs residing in the bone marrow microenvironment (BMME) functionally interact with hematopoietic stem progenitor cells regulating hematopoiesis. However, MSCs have also emerged in recent years as key regulators of the tumor microenvironment. Indeed, they are now considered active players in the pathophysiology of hematologic malignancies rather than passive bystanders in the hematopoietic microenvironment. Once a malignant event occurs, the BMME acquires cellular, molecular, and epigenetic abnormalities affecting tumor growth and progression. In this context, MSC behavior is affected by signals coming from cancer cells. Furthermore, it has been shown that stromal cells themselves play a major role in several hematological malignancies\u2019 pathogenesis. This bidirectional crosstalk creates a functional tumor niche unit wherein tumor cells acquire a selective advantage over their normal counterparts and are protected from drug treatment. It is therefore of critical importance to unveil the underlying mechanisms which activate a protumor phenotype of MSCs for defining the unmasked vulnerabilities of hematological cancer cells which could be pharmacologically exploited to disrupt tumor\/MSC coupling. The present review focuses on the current knowledge about MSC dysfunction mechanisms in the BMME of hematological cancers, sustaining tumor growth, immune escape, and cancer progression.<\/jats:p>","DOI":"10.3390\/biom13121701","type":"journal-article","created":{"date-parts":[[2023,11,24]],"date-time":"2023-11-24T03:43:59Z","timestamp":1700797439000},"page":"1701","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":20,"title":["Engagement of Mesenchymal Stromal Cells in the Remodeling of the Bone Marrow Microenvironment in Hematological Cancers"],"prefix":"10.3390","volume":"13","author":[{"given":"Sebastiano","family":"Giallongo","sequence":"first","affiliation":[{"name":"Department of Medical, Surgical Sciences and Advanced Technologies \u201cG.F. Ingrassia\u201d, University of Catania, 95123 Catania, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9510-4755","authenticated-orcid":false,"given":"Andrea","family":"Duminuco","sequence":"additional","affiliation":[{"name":"Division of Hematology, AOU Policlinico, 95123 Catania, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ilaria","family":"Dulcamare","sequence":"additional","affiliation":[{"name":"Department of Clinical and Experimental Medicine, University of Catania, 95123 Catania, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0006-2148-7606","authenticated-orcid":false,"given":"Tatiana","family":"Zuppelli","sequence":"additional","affiliation":[{"name":"Department of Biomedical and Biotechnological Sciences, University of Catania, 95123 Catania, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Enrico","family":"La Spina","sequence":"additional","affiliation":[{"name":"Department of Biomedical and Biotechnological Sciences, University of Catania, 95123 Catania, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Grazia","family":"Scandura","sequence":"additional","affiliation":[{"name":"Department of General Surgery and Medical-Surgical Specialties, University of Catania, 95123 Catania, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annalisa","family":"Santisi","sequence":"additional","affiliation":[{"name":"Division of Hematology, AOU Policlinico, 95123 Catania, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6333-4433","authenticated-orcid":false,"given":"Alessandra","family":"Romano","sequence":"additional","affiliation":[{"name":"Department of General Surgery and Medical-Surgical Specialties, University of Catania, 95123 Catania, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesco","family":"Di Raimondo","sequence":"additional","affiliation":[{"name":"Department of General Surgery and Medical-Surgical Specialties, University of Catania, 95123 Catania, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4416-8556","authenticated-orcid":false,"given":"Daniele","family":"Tibullo","sequence":"additional","affiliation":[{"name":"Department of Biomedical and Biotechnological Sciences, University of Catania, 95123 Catania, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1859-6319","authenticated-orcid":false,"given":"Giuseppe A.","family":"Palumbo","sequence":"additional","affiliation":[{"name":"Department of Medical, Surgical Sciences and Advanced Technologies \u201cG.F. Ingrassia\u201d, University of Catania, 95123 Catania, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cesarina","family":"Giallongo","sequence":"additional","affiliation":[{"name":"Department of Medical, Surgical Sciences and Advanced Technologies \u201cG.F. Ingrassia\u201d, University of Catania, 95123 Catania, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2023,11,24]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1016\/j.immuni.2018.03.024","article-title":"Niches for Hematopoietic Stem Cells and Their Progeny","volume":"48","author":"Wei","year":"2018","journal-title":"Immunity"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1038\/nature11885","article-title":"Haematopoietic stem cells and early lymphoid progenitors occupy distinct bone marrow niches","volume":"495","author":"Ding","year":"2013","journal-title":"Nature"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.1016\/j.immuni.2016.11.004","article-title":"Hematopoietic Stem Cell Niches Produce Lineage-Instructive Signals to Control Multipotent Progenitor Differentiation","volume":"45","author":"Hara","year":"2016","journal-title":"Immunity"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.1242\/dev.01615","article-title":"Mesenchymal progenitor cells localize within hematopoietic sites throughout ontogeny","volume":"132","author":"Mendes","year":"2005","journal-title":"Development"},{"key":"ref_5","doi-asserted-by":"crossref","unstructured":"Fallati, A., Di Marzo, N., D\u2019Amico, G., and Dander, E. (2022). Mesenchymal Stromal Cells (MSCs): An Ally of B-Cell Acute Lymphoblastic Leukemia (B-ALL) Cells in Disease Maintenance and Progression within the Bone Marrow Hematopoietic Niche. Cancers, 14.","DOI":"10.3390\/cancers14143303"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"1422","DOI":"10.1182\/blood-2009-08-239194","article-title":"Isolation and characterization of endosteal niche cell populations that regulate hematopoietic stem cells","volume":"116","author":"Nakamura","year":"2010","journal-title":"Blood"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"5067","DOI":"10.1182\/blood-2010-08-304287","article-title":"CD146 expression on primary nonhematopoietic bone marrow stem cells is correlated with in situ localization","volume":"117","author":"Tormin","year":"2011","journal-title":"Blood"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1016\/j.immuni.2006.10.016","article-title":"Maintenance of the hematopoietic stem cell pool by CXCL12-CXCR4 chemokine signaling in bone marrow stromal cell niches","volume":"25","author":"Sugiyama","year":"2006","journal-title":"Immunity"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"2834","DOI":"10.1182\/blood-2013-07-517219","article-title":"Inhibition of leukemia cell engraftment and disease progression in mice by osteoblasts","volume":"124","author":"Krevvata","year":"2014","journal-title":"Blood"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"2678","DOI":"10.1182\/blood-2014-06-582924","article-title":"Osteoblast ablation reduces normal long-term hematopoietic stem cell self-renewal but accelerates leukemia development","volume":"125","author":"Bowers","year":"2015","journal-title":"Blood"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"194","DOI":"10.3324\/haematol.2014.109769","article-title":"Down-regulation of Dicer1 promotes cellular senescence and decreases the differentiation and stem cell-supporting capacities of mesenchymal stromal cells in patients with myelodysplastic syndrome","volume":"100","author":"Zhao","year":"2015","journal-title":"Haematologica"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"10","DOI":"10.21037\/sci-2020-036","article-title":"Safety and therapeutic potential of human bone marrow-derived mesenchymal stromal cells in regenerative medicine","volume":"8","author":"Aithal","year":"2021","journal-title":"Stem Cell Investig."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1016\/j.stem.2013.09.006","article-title":"Mesenchymal stromal cells: Sensors and switchers of inflammation","volume":"13","author":"Bernardo","year":"2013","journal-title":"Cell Stem Cell"},{"key":"ref_14","doi-asserted-by":"crossref","unstructured":"Ruiz-Aparicio, P.F., and Vernot, J.P. (2022). Bone Marrow Aging and the Leukaemia-Induced Senescence of Mesenchymal Stem\/Stromal Cells: Exploring Similarities. J. Pers. Med., 12.","DOI":"10.3390\/jpm12050716"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1038\/nrclinonc.2017.197","article-title":"The bone-marrow niche in MDS and MGUS: Implications for AML and MM","volume":"15","author":"Ghobrial","year":"2018","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1093\/stcltm\/szac004","article-title":"Mesenchymal Stem\/Stromal Cell Senescence: Hallmarks, Mechanisms, and Combating Strategies","volume":"11","author":"Weng","year":"2022","journal-title":"Stem Cells Transl. Med."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"107817","DOI":"10.1016\/j.pharmthera.2021.107817","article-title":"Cellular senescence and hematological malignancies: From pathogenesis to therapeutics","volume":"223","author":"Hu","year":"2021","journal-title":"Pharmacol. Ther."},{"key":"ref_18","doi-asserted-by":"crossref","unstructured":"Chen, X., Li, N., Weng, J., and Du, X. (2020). Senescent Mesenchymal Stem Cells in Myelodysplastic Syndrome: Functional Alterations, Molecular Mechanisms, and Therapeutic Strategies. Front. Cell Dev. Biol., 8.","DOI":"10.3389\/fcell.2020.617466"},{"key":"ref_19","doi-asserted-by":"crossref","unstructured":"Vanegas, N.P., Ruiz-Aparicio, P.F., Uribe, G.I., Linares-Ballesteros, A., and Vernot, J.P. (2021). Leukemia-Induced Cellular Senescence and Stemness Alterations in Mesenchymal Stem Cells Are Reversible upon Withdrawal of B-Cell Acute Lymphoblastic Leukemia Cells. Int. J. Mol. Sci., 22.","DOI":"10.3390\/ijms22158166"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"13285","DOI":"10.18632\/oncotarget.7690","article-title":"Increased IL-6 secretion by aged human mesenchymal stromal cells disrupts hematopoietic stem and progenitor cells\u2019 homeostasis","volume":"7","author":"Nadeau","year":"2016","journal-title":"Oncotarget"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1016\/j.stem.2015.05.002","article-title":"Aging-Induced Stem Cell Mutations as Drivers for Disease and Cancer","volume":"16","author":"Adams","year":"2015","journal-title":"Cell Stem Cell"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"5583","DOI":"10.1182\/blood-2011-03-343467","article-title":"Mesenchymal stromal cells of myelodysplastic syndrome and acute myeloid leukemia patients have distinct genetic abnormalities compared with leukemic blasts","volume":"118","author":"Blau","year":"2011","journal-title":"Blood"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1186\/s13287-021-02444-0","article-title":"Bone marrow-derived mesenchymal stem\/stromal cells in patients with acute myeloid leukemia reveal transcriptome alterations and deficiency in cellular vitality","volume":"12","author":"Zhang","year":"2021","journal-title":"Stem Cell Res. Ther."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1016\/j.stem.2014.02.014","article-title":"Myelodysplastic cells in patients reprogram mesenchymal stromal cells to establish a transplantable stem cell niche disease unit","volume":"14","author":"Medyouf","year":"2014","journal-title":"Cell Stem Cell"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.tcb.2019.11.006","article-title":"Epigenetic Regulation of Mesenchymal Stem Cell Homeostasis","volume":"30","author":"Sui","year":"2020","journal-title":"Trends Cell Biol."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"4846","DOI":"10.1158\/0008-5472.CAN-17-0282","article-title":"Epigenetically Aberrant Stroma in MDS Propagates Disease via Wnt\/beta-Catenin Activation","volume":"77","author":"Bhagat","year":"2017","journal-title":"Cancer Res."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1038\/s41467-020-20715-x","article-title":"Targeting aberrant DNA methylation in mesenchymal stromal cells as a treatment for myeloma bone disease","volume":"12","author":"Li","year":"2021","journal-title":"Nat. Commun."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"1542","DOI":"10.1038\/s41375-019-0406-z","article-title":"Correction: Bone marrow MSCs in MDS: Contribution towards dysfunctional hematopoiesis and potential targets for disease response to hypomethylating therapy","volume":"33","author":"Poon","year":"2019","journal-title":"Leukemia"},{"key":"ref_29","first-page":"679","article-title":"Use of methylation profiling to identify significant differentially methylated genes in bone marrow mesenchymal stromal cells from acute myeloid leukemia","volume":"41","author":"Huang","year":"2018","journal-title":"Int. J. Mol. Med."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1038\/leu.2015.289","article-title":"Halting pro-survival autophagy by TGFbeta inhibition in bone marrow fibroblasts overcomes bortezomib resistance in multiple myeloma patients","volume":"30","author":"Frassanito","year":"2016","journal-title":"Leukemia"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1186\/s13046-016-0405-0","article-title":"Growth differentiation factor 15 contributes to cancer-associated fibroblasts-mediated chemo-protection of AML cells","volume":"35","author":"Zhai","year":"2016","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"1415","DOI":"10.1182\/blood.2019001398","article-title":"Activated stromal cells transfer mitochondria to rescue acute lymphoblastic leukemia cells from oxidative stress","volume":"134","author":"Burt","year":"2019","journal-title":"Blood"},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"1413","DOI":"10.4161\/cbt.29924","article-title":"Fibroblast activation protein protects bortezomib-induced apoptosis in multiple myeloma cells through beta-catenin signaling pathway","volume":"15","author":"Zi","year":"2014","journal-title":"Cancer Biol. Ther."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1016\/j.ccr.2014.04.015","article-title":"Leukemia propagating cells rebuild an evolving niche in response to therapy","volume":"25","author":"Duan","year":"2014","journal-title":"Cancer Cell"},{"key":"ref_35","doi-asserted-by":"crossref","unstructured":"Pan, C., Fang, Q., Liu, P., Ma, D., Cao, S., Zhang, L., Chen, Q., Hu, T., and Wang, J. (2021). Mesenchymal Stem Cells With Cancer-Associated Fibroblast-Like Phenotype Stimulate SDF-1\/CXCR4 Axis to Enhance the Growth and Invasion of B-Cell Acute Lymphoblastic Leukemia Cells Through Cell-to-Cell Communication. Front. Cell Dev. Biol., 9.","DOI":"10.3389\/fcell.2021.708513"},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"2268","DOI":"10.1002\/2211-5463.12976","article-title":"Adipose-derived mesenchymal stem cells differentiate into pancreatic cancer-associated fibroblasts in vitro","volume":"10","author":"Miyazaki","year":"2020","journal-title":"FEBS Open Bio"},{"key":"ref_37","doi-asserted-by":"crossref","unstructured":"Rubinstein-Achiasaf, L., Morein, D., Ben-Yaakov, H., Liubomirski, Y., Meshel, T., Elbaz, E., Dorot, O., Pichinuk, E., Gershovits, M., and Weil, M. (2021). Persistent Inflammatory Stimulation Drives the Conversion of MSCs to Inflammatory CAFs That Promote Pro-Metastatic Characteristics in Breast Cancer Cells. Cancers, 13.","DOI":"10.3390\/cancers13061472"},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1111\/j.1582-4934.2010.01044.x","article-title":"Tumour-associated fibroblasts and mesenchymal stem cells: More similarities than differences","volume":"15","author":"Paunescu","year":"2011","journal-title":"J. Cell. Mol. Med."},{"key":"ref_39","doi-asserted-by":"crossref","unstructured":"Longhitano, L., Li Volti, G., Giallongo, C., Spampinato, M., Barbagallo, I., Di Rosa, M., Romano, A., Avola, R., Tibullo, D., and Palumbo, G.A. (2020). The Role of Inflammation and Inflammasome in Myeloproliferative Disease. J. Clin. Med., 9.","DOI":"10.3390\/jcm9082334"},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"8284","DOI":"10.18632\/oncotarget.2058","article-title":"Transcriptomic profile induced in bone marrow mesenchymal stromal cells after interaction with multiple myeloma cells: Implications in myeloma progression and myeloma bone disease","volume":"5","author":"Ocio","year":"2014","journal-title":"Oncotarget"},{"key":"ref_41","doi-asserted-by":"crossref","unstructured":"Giallongo, C., Romano, A., Parrinello, N.L., La Cava, P., Brundo, M.V., Bramanti, V., Stagno, F., Vigneri, P., Chiarenza, A., and Palumbo, G.A. (2016). Mesenchymal Stem Cells (MSC) Regulate Activation of Granulocyte-Like Myeloid Derived Suppressor Cells (G-MDSC) in Chronic Myeloid Leukemia Patients. PLoS ONE, 11.","DOI":"10.1371\/journal.pone.0158392"},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"3943","DOI":"10.7150\/thno.83178","article-title":"BCR-ABL1-driven exosome-miR130b-3p-mediated gap-junction Cx43 MSC intercellular communications imply therapies of leukemic subclonal evolution","volume":"13","author":"Chai","year":"2023","journal-title":"Theranostics"},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1002\/stem.3185","article-title":"Mesenchymal stromal cells induce regulatory T cells via epigenetic conversion of human conventional CD4 T cells in vitro","volume":"38","author":"Azevedo","year":"2020","journal-title":"Stem Cells"},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"1078421","DOI":"10.3389\/fimmu.2022.1078421","article-title":"The immunological role of mesenchymal stromal cells in patients with myelodysplastic syndrome","volume":"13","author":"Zheng","year":"2022","journal-title":"Front. Immunol."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"3793","DOI":"10.1158\/1078-0432.CCR-20-2188","article-title":"Bone Marrow Mesenchymal Stromal Cells Can Render Multiple Myeloma Cells Resistant to Cytotoxic Machinery of CAR T Cells through Inhibition of Apoptosis","volume":"27","author":"Holthof","year":"2021","journal-title":"Clin. Cancer Res."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1038\/s41419-019-1959-5","article-title":"TLR4 signaling drives mesenchymal stromal cells commitment to promote tumor microenvironment transformation in multiple myeloma","volume":"10","author":"Giallongo","year":"2019","journal-title":"Cell Death Dis."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"1505","DOI":"10.1038\/cdd.2012.26","article-title":"Mesenchymal stem cells: A double-edged sword in regulating immune responses","volume":"19","author":"Li","year":"2012","journal-title":"Cell Death Differ."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"4705654","DOI":"10.1155\/2022\/4705654","article-title":"MSC Senescence-Related Genes Are Associated with Myeloma Prognosis and Lipid Metabolism-Mediated Resistance to Proteasome Inhibitors","volume":"2022","author":"Cao","year":"2022","journal-title":"J. Oncol."},{"key":"ref_49","doi-asserted-by":"crossref","unstructured":"Waterman, R.S., Tomchuck, S.L., Henkle, S.L., and Betancourt, A.M. (2010). A new mesenchymal stem cell (MSC) paradigm: Polarization into a pro-inflammatory MSC1 or an Immunosuppressive MSC2 phenotype. PLoS ONE, 5.","DOI":"10.1371\/journal.pone.0010088"},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"2210","DOI":"10.1002\/stem.2372","article-title":"Mitochondrial Transfer via Tunneling Nanotubes is an Important Mechanism by Which Mesenchymal Stem Cells Enhance Macrophage Phagocytosis in the In Vitro and In Vivo Models of ARDS","volume":"34","author":"Jackson","year":"2016","journal-title":"Stem Cells"},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"726909","DOI":"10.3389\/fimmu.2021.726909","article-title":"Regulation of Inflammatory Cytokine Storms by Mesenchymal Stem Cells","volume":"12","author":"Wang","year":"2021","journal-title":"Front. Immunol."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"623973","DOI":"10.3389\/fimmu.2021.623973","article-title":"Mesenchymal Stromal Cell-Derived Extracellular Vesicles Regulate the Mitochondrial Metabolism via Transfer of miRNAs","volume":"12","author":"Loussouarn","year":"2021","journal-title":"Front. Immunol."},{"key":"ref_53","doi-asserted-by":"crossref","unstructured":"Thomas, M.A., Fahey, M.J., Pugliese, B.R., Irwin, R.M., Antonyak, M.A., and Delco, M.L. (2022). Human mesenchymal stromal cells release functional mitochondria in extracellular vesicles. Front. Bioeng. Biotechnol., 10.","DOI":"10.3389\/fbioe.2022.870193"},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1002\/2211-5463.13352","article-title":"Bone marrow-mesenchymal stem cell-derived extracellular vesicles affect proliferation and apoptosis of leukemia cells in vitro","volume":"12","author":"Phetfong","year":"2022","journal-title":"FEBS Open Bio"},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1038\/s41389-022-00380-z","article-title":"CXCL12\/CXCR4 axis supports mitochondrial trafficking in tumor myeloma microenvironment","volume":"11","author":"Giallongo","year":"2022","journal-title":"Oncogenesis"},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"e75908","DOI":"10.7554\/eLife.75908","article-title":"Crosstalk between AML and stromal cells triggers acetate secretion through the metabolic rewiring of stromal cells","volume":"11","author":"Cuminetti","year":"2022","journal-title":"eLife"},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"1155621","DOI":"10.3389\/fonc.2023.1155621","article-title":"Metabolic changes underlying drug resistance in the multiple myeloma tumor microenvironment","volume":"13","author":"Chang","year":"2023","journal-title":"Front. Oncol."},{"key":"ref_58","doi-asserted-by":"crossref","unstructured":"Chiu, M., Toscani, D., Marchica, V., Taurino, G., Costa, F., Bianchi, M.G., Andreoli, R., Franceschi, V., Storti, P., and Burroughs-Garcia, J. (2020). Myeloma Cells Deplete Bone Marrow Glutamine and Inhibit Osteoblast Differentiation Limiting Asparagine Availability. Cancers, 12.","DOI":"10.3390\/cancers12113267"},{"key":"ref_59","doi-asserted-by":"crossref","unstructured":"Giallongo, C., Tibullo, D., Puglisi, F., Barbato, A., Vicario, N., Cambria, D., Parrinello, N.L., Romano, A., Conticello, C., and Forte, S. (2020). Inhibition of TLR4 Signaling Affects Mitochondrial Fitness and Overcomes Bortezomib Resistance in Myeloma Plasma Cells. Cancers, 12.","DOI":"10.3390\/cancers12081999"},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"e1139","DOI":"10.1002\/cnr2.1139","article-title":"Metabolic underpinnings of leukemia pathology and treatment","volume":"2","author":"Nemkov","year":"2019","journal-title":"Cancer Rep."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1016\/j.cmet.2019.08.013","article-title":"Mechanisms and Implications of Metabolic Heterogeneity in Cancer","volume":"30","author":"Kim","year":"2019","journal-title":"Cell Metab."},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1038\/leu.2017.259","article-title":"Acute myeloid leukemia transforms the bone marrow niche into a leukemia-permissive microenvironment through exosome secretion","volume":"32","author":"Kumar","year":"2018","journal-title":"Leukemia"},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1093\/carcin\/bgz169","article-title":"Multiple myeloma BM-MSCs increase the tumorigenicity of MM cells via transfer of VLA4-enriched microvesicles","volume":"41","author":"Dabbah","year":"2020","journal-title":"Carcinogenesis"},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1093\/carcin\/bgx045","article-title":"Microvesicles derived from normal and multiple myeloma bone marrow mesenchymal stem cells differentially modulate myeloma cells\u2019 phenotype and translation initiation","volume":"38","author":"Dabbah","year":"2017","journal-title":"Carcinogenesis"},{"key":"ref_65","unstructured":"Dotson, J.L., and Lebowicz, Y. (2023). StatPearls, StatPearls Publishing."},{"key":"ref_66","doi-asserted-by":"crossref","unstructured":"Stahl, M., Bewersdorf, J.P., Xie, Z., Porta, M.G.D., Komrokji, R., Xu, M.L., Abdel-Wahab, O., Taylor, J., Steensma, D.P., and Starczynowski, D.T. (Blood Rev., 2023). Classification, risk stratification and response assessment in myelodysplastic syndromes\/neoplasms (MDS): A state-of-the-art report on behalf of the International Consortium for MDS (icMDS), Blood Rev., in press.","DOI":"10.1016\/j.blre.2023.101128"},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"101113","DOI":"10.1016\/j.beha.2019.101113","article-title":"What is the role of the microenvironment in MDS?","volume":"32","author":"Calvi","year":"2019","journal-title":"Best. Pract. Res. Clin. Haematol."},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1038\/leu.2008.361","article-title":"Both expanded and uncultured mesenchymal stem cells from MDS patients are genomically abnormal, showing a specific genetic profile for the 5q- syndrome","volume":"23","author":"Garcia","year":"2009","journal-title":"Leukemia"},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"1604","DOI":"10.1089\/scd.2011.0390","article-title":"Intrinsic growth deficiencies of mesenchymal stromal cells in myelodysplastic syndromes","volume":"21","author":"Aanei","year":"2012","journal-title":"Stem Cells Dev."},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"1920","DOI":"10.1002\/jbmr.2892","article-title":"Identification of Senescent Cells in the Bone Microenvironment","volume":"31","author":"Farr","year":"2016","journal-title":"J. Bone Miner. Res."},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"6170","DOI":"10.1038\/s41467-021-26424-3","article-title":"Bone marrow derived stromal cells from myelodysplastic syndromes are altered but not clonally mutated in vivo","volume":"12","author":"Jann","year":"2021","journal-title":"Nat. Commun."},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1111\/ejh.12385","article-title":"Senescence of bone marrow mesenchymal stromal cells is accompanied by activation of p53\/p21 pathway in myelodysplastic syndromes","volume":"93","author":"Fei","year":"2014","journal-title":"Eur. J. Haematol."},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1111\/bjh.14115","article-title":"DNA demethylating therapy reverts mesenchymal stromal cells derived from high risk myelodysplastic patients to a normal phenotype","volume":"177","author":"Maurizi","year":"2017","journal-title":"Br. J. Haematol."},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"3447","DOI":"10.1182\/bloodadvances.2018022053","article-title":"Direct modulation of the bone marrow mesenchymal stromal cell compartment by azacitidine enhances healthy hematopoiesis","volume":"2","author":"Wenk","year":"2018","journal-title":"Blood Adv."},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1016\/j.stem.2016.08.021","article-title":"Mesenchymal Inflammation Drives Genotoxic Stress in Hematopoietic Stem Cells and Predicts Disease Evolution in Human Pre-leukemia","volume":"19","author":"Zambetti","year":"2016","journal-title":"Cell Stem Cell"},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"172","DOI":"10.3389\/fonc.2016.00172","article-title":"Bone Marrow Immunity and Myelodysplasia","volume":"6","author":"Lambert","year":"2016","journal-title":"Front. Oncol."},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"e87","DOI":"10.1038\/bcj.2012.36","article-title":"Stromal cells expressing hedgehog-interacting protein regulate the proliferation of myeloid neoplasms","volume":"2","author":"Kobune","year":"2012","journal-title":"Blood Cancer J."},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1038\/s41419-023-06197-x","article-title":"MacroH2A1.1 as a crossroad between epigenetics, inflammation and metabolism of mesenchymal stromal cells in myelodysplastic syndromes","volume":"14","author":"Giallongo","year":"2023","journal-title":"Cell Death Dis."},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"1938","DOI":"10.1038\/leu.2016.91","article-title":"Massive parallel RNA sequencing of highly purified mesenchymal elements in low-risk MDS reveals tissue-context-dependent activation of inflammatory programs","volume":"30","author":"Chen","year":"2016","journal-title":"Leukemia"},{"key":"ref_80","doi-asserted-by":"crossref","unstructured":"Pleyer, L., Valent, P., and Greil, R. (2016). Mesenchymal Stem and Progenitor Cells in Normal and Dysplastic Hematopoiesis-Masters of Survival and Clonality?. Int. J. Mol. Sci., 17.","DOI":"10.3390\/ijms17071009"},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1016\/j.scr.2015.01.006","article-title":"Despite differential gene expression profiles pediatric MDS derived mesenchymal stromal cells display functionality in vitro","volume":"14","author":"Calkoen","year":"2015","journal-title":"Stem Cell Res."},{"key":"ref_82","doi-asserted-by":"crossref","unstructured":"Kim, M., Hwang, S., Park, K., Kim, S.Y., Lee, Y.K., and Lee, D.S. (2015). Increased expression of interferon signaling genes in the bone marrow microenvironment of myelodysplastic syndromes. PLoS ONE, 10.","DOI":"10.1371\/journal.pone.0120602"},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"110805","DOI":"10.1016\/j.celrep.2022.110805","article-title":"MDS cells impair osteolineage differentiation of MSCs via extracellular vesicles to suppress normal hematopoiesis","volume":"39","author":"Hayashi","year":"2022","journal-title":"Cell Rep."},{"key":"ref_84","doi-asserted-by":"crossref","unstructured":"Muntion, S., Ramos, T.L., Diez-Campelo, M., Roson, B., Sanchez-Abarca, L.I., Misiewicz-Krzeminska, I., Preciado, S., Sarasquete, M.E., de Las Rivas, J., and Gonzalez, M. (2016). Microvesicles from Mesenchymal Stromal Cells Are Involved in HPC-Microenvironment Crosstalk in Myelodysplastic Patients. PLoS ONE, 11.","DOI":"10.1371\/journal.pone.0146722"},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"1270","DOI":"10.1002\/stem.3387","article-title":"Acute myeloid leukemia-induced functional inhibition of healthy CD34+ hematopoietic stem and progenitor cells","volume":"39","author":"Jager","year":"2021","journal-title":"Stem Cells"},{"key":"ref_86","doi-asserted-by":"crossref","unstructured":"Pan, C., Liu, P., Ma, D., Zhang, S., Ni, M., Fang, Q., and Wang, J. (2020). Bone marrow mesenchymal stem cells in microenvironment transform into cancer-associated fibroblasts to promote the progression of B-cell acute lymphoblastic leukemia. Biomed. Pharmacother., 130.","DOI":"10.1016\/j.biopha.2020.110610"},{"key":"ref_87","doi-asserted-by":"crossref","unstructured":"Leotta, S., Condorelli, A., Sciortino, R., Milone, G.A., Bellofiore, C., Garibaldi, B., Schinina, G., Spadaro, A., Cupri, A., and Milone, G. (2022). Prevention and Treatment of Acute Myeloid Leukemia Relapse after Hematopoietic Stem Cell Transplantation: The State of the Art and Future Perspectives. J. Clin. Med., 11.","DOI":"10.3390\/jcm11010253"},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"1861","DOI":"10.1126\/science.1164390","article-title":"Leukemic cells create bone marrow niches that disrupt the behavior of normal hematopoietic progenitor cells","volume":"322","author":"Colmone","year":"2008","journal-title":"Science"},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"e83533","DOI":"10.7554\/eLife.83533","article-title":"Cell circuits between leukemic cells and mesenchymal stem cells block lymphopoiesis by activating lymphotoxin beta receptor signaling","volume":"12","author":"Feng","year":"2023","journal-title":"eLife"},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/j.canlet.2015.08.006","article-title":"The molecular signature of AML mesenchymal stromal cells reveals candidate genes related to the leukemogenic process","volume":"369","author":"Binato","year":"2015","journal-title":"Cancer Lett."},{"key":"ref_91","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1038\/leu.2015.210","article-title":"Altered mesenchymal niche cells impede generation of normal hematopoietic progenitor cells in leukemic bone marrow","volume":"30","author":"Lim","year":"2016","journal-title":"Leukemia"},{"key":"ref_92","doi-asserted-by":"crossref","first-page":"21231","DOI":"10.1038\/s41598-022-24644-1","article-title":"Impairment of FOXM1 expression in mesenchymal cells from patients with myeloid neoplasms, de novo and therapy-related, may compromise their ability to support hematopoiesis","volume":"12","author":"Falconi","year":"2022","journal-title":"Sci. Rep."},{"key":"ref_93","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1038\/leu.2015.325","article-title":"Functional inhibition of mesenchymal stromal cells in acute myeloid leukemia","volume":"30","author":"Geyh","year":"2016","journal-title":"Leukemia"},{"key":"ref_94","first-page":"557","article-title":"Targeting the plasticity of mesenchymal stromal cells to reroute the course of acute myeloid leukemia","volume":"138","author":"Borella","year":"2021","journal-title":"Blood"},{"key":"ref_95","doi-asserted-by":"crossref","first-page":"3635","DOI":"10.1002\/stem.2208","article-title":"Functional Niche Competition Between Normal Hematopoietic Stem and Progenitor Cells and Myeloid Leukemia Cells","volume":"33","author":"Desmond","year":"2015","journal-title":"Stem Cells"},{"key":"ref_96","doi-asserted-by":"crossref","first-page":"2222","DOI":"10.1158\/0008-5472.CAN-14-3379","article-title":"Microenvironmental remodeling as a parameter and prognostic factor of heterogeneous leukemogenesis in acute myelogenous leukemia","volume":"75","author":"Kim","year":"2015","journal-title":"Cancer Res."},{"key":"ref_97","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.exphem.2017.01.008","article-title":"The evolving view of the hematopoietic stem cell niche","volume":"50","author":"Beerman","year":"2017","journal-title":"Exp. Hematol."},{"key":"ref_98","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1007\/s12015-015-9639-z","article-title":"Adipogenic Mesenchymal Stromal Cells from Bone Marrow and Their Hematopoietic Supportive Role: Towards Understanding the Permissive Marrow Microenvironment in Acute Myeloid Leukemia","volume":"12","author":"Le","year":"2016","journal-title":"Stem Cell Rev. Rep."},{"key":"ref_99","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1038\/s41375-019-0568-8","article-title":"Bone marrow mesenchymal stromal cells from acute myelogenous leukemia patients demonstrate adipogenic differentiation propensity with implications for leukemia cell support","volume":"34","author":"Azadniv","year":"2020","journal-title":"Leukemia"},{"key":"ref_100","doi-asserted-by":"crossref","first-page":"e90036","DOI":"10.1172\/jci.insight.90036","article-title":"AML-induced osteogenic differentiation in mesenchymal stromal cells supports leukemia growth","volume":"2","author":"Battula","year":"2017","journal-title":"JCI Insight"},{"key":"ref_101","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1016\/j.stem.2014.06.020","article-title":"Acute myelogenous leukemia-induced sympathetic neuropathy promotes malignancy in an altered hematopoietic stem cell niche","volume":"15","author":"Hanoun","year":"2014","journal-title":"Cell Stem Cell"},{"key":"ref_102","doi-asserted-by":"crossref","first-page":"2105811","DOI":"10.1002\/advs.202105811","article-title":"Acute Myeloid Leukemia Cells Educate Mesenchymal Stromal Cells toward an Adipogenic Differentiation Propensity with Leukemia Promotion Capabilities","volume":"9","author":"Zhang","year":"2022","journal-title":"Adv. Sci."},{"key":"ref_103","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1182\/blood-2018-04-845420","article-title":"Acute myeloid leukemia induces protumoral p16INK4a-driven senescence in the bone marrow microenvironment","volume":"133","author":"Sun","year":"2019","journal-title":"Blood"},{"key":"ref_104","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/j.cell.2007.07.003","article-title":"Cellular senescence in cancer and aging","volume":"130","author":"Collado","year":"2007","journal-title":"Cell"},{"key":"ref_105","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1089\/scd.2020.0166","article-title":"The Chromatin Remodeling Complex CHD1 Regulates the Primitive State of Mesenchymal Stromal Cells to Control Their Stem Cell Supporting Activity","volume":"30","author":"Lee","year":"2021","journal-title":"Stem Cells Dev."},{"key":"ref_106","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1053\/j.seminoncol.2017.10.004","article-title":"Metabolic coupling and the Reverse Warburg Effect in cancer: Implications for novel biomarker and anticancer agent development","volume":"44","author":"Wilde","year":"2017","journal-title":"Semin. Oncol."},{"key":"ref_107","doi-asserted-by":"crossref","unstructured":"Baccelli, I., Gareau, Y., Lehnertz, B., Gingras, S., Spinella, J.F., Corneau, S., Mayotte, N., Girard, S., Frechette, M., and Blouin-Chagnon, V. (2019). Mubritinib Targets the Electron Transport Chain Complex I and Reveals the Landscape of OXPHOS Dependency in Acute Myeloid Leukemia. Cancer Cell, 36.","DOI":"10.2139\/ssrn.3376657"},{"key":"ref_108","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1158\/2159-8290.CD-16-0441","article-title":"Chemotherapy-Resistant Human Acute Myeloid Leukemia Cells Are Not Enriched for Leukemic Stem Cells but Require Oxidative Metabolism","volume":"7","author":"Farge","year":"2017","journal-title":"Cancer Discov."},{"key":"ref_109","doi-asserted-by":"crossref","unstructured":"Forte, D., Garcia-Fernandez, M., Sanchez-Aguilera, A., Stavropoulou, V., Fielding, C., Martin-Perez, D., Lopez, J.A., Costa, A.S.H., Tronci, L., and Nikitopoulou, E. (2020). Bone Marrow Mesenchymal Stem Cells Support Acute Myeloid Leukemia Bioenergetics and Enhance Antioxidant Defense and Escape from Chemotherapy. Cell Metab., 32.","DOI":"10.1016\/j.cmet.2020.09.001"},{"key":"ref_110","doi-asserted-by":"crossref","first-page":"1649","DOI":"10.1182\/blood-2017-03-772939","article-title":"NADPH oxidase-2 derived superoxide drives mitochondrial transfer from bone marrow stromal cells to leukemic blasts","volume":"130","author":"Marlein","year":"2017","journal-title":"Blood"},{"key":"ref_111","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1182\/blood-2015-07-655860","article-title":"Protective mitochondrial transfer from bone marrow stromal cells to acute myeloid leukemic cells during chemotherapy","volume":"128","author":"Moschoi","year":"2016","journal-title":"Blood"},{"key":"ref_112","doi-asserted-by":"crossref","first-page":"589","DOI":"10.3324\/haematol.2019.242974","article-title":"Daratumumab inhibits acute myeloid leukaemia metabolic capacity by blocking mitochondrial transfer from mesenchymal stromal cells","volume":"106","author":"Mistry","year":"2021","journal-title":"Haematologica"},{"key":"ref_113","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1186\/s13045-018-0554-z","article-title":"Cell adhesion-mediated mitochondria transfer contributes to mesenchymal stem cell-induced chemoresistance on T cell acute lymphoblastic leukemia cells","volume":"11","author":"Wang","year":"2018","journal-title":"J. Hematol. Oncol."},{"key":"ref_114","doi-asserted-by":"crossref","first-page":"1320","DOI":"10.1182\/blood-2016-08-734798","article-title":"Leukemic blasts program bone marrow adipocytes to generate a protumoral microenvironment","volume":"129","author":"Shafat","year":"2017","journal-title":"Blood"},{"key":"ref_115","doi-asserted-by":"crossref","first-page":"25655","DOI":"10.1074\/jbc.M111.228692","article-title":"Mitochondrial carnitine palmitoyltransferase 1a (CPT1a) is part of an outer membrane fatty acid transfer complex","volume":"286","author":"Lee","year":"2011","journal-title":"J. Biol. Chem."},{"key":"ref_116","doi-asserted-by":"crossref","first-page":"665763","DOI":"10.3389\/fonc.2021.665763","article-title":"Adipocytes Provide Fatty Acids to Acute Lymphoblastic Leukemia Cells","volume":"11","author":"Tucci","year":"2021","journal-title":"Front. Oncol."},{"key":"ref_117","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1182\/blood-2015-12-688051","article-title":"Metabolic reprogramming of bone marrow stromal cells by leukemic extracellular vesicles in acute lymphoblastic leukemia","volume":"128","author":"Johnson","year":"2016","journal-title":"Blood"},{"key":"ref_118","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1038\/s41408-018-0054-y","article-title":"The 2016 WHO classification and diagnostic criteria for myeloproliferative neoplasms: Document summary and in-depth discussion","volume":"8","author":"Barbui","year":"2018","journal-title":"Blood Cancer J."},{"key":"ref_119","doi-asserted-by":"crossref","unstructured":"Nasillo, V., Riva, G., Paolini, A., Forghieri, F., Roncati, L., Lusenti, B., Maccaferri, M., Messerotti, A., Pioli, V., and Gilioli, A. (2021). Inflammatory Microenvironment and Specific T Cells in Myeloproliferative Neoplasms: Immunopathogenesis and Novel Immunotherapies. Int. J. Mol. Sci., 22.","DOI":"10.3390\/ijms22041906"},{"key":"ref_120","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1007\/s00277-020-04306-w","article-title":"Heterogeneity of the bone marrow niche in patients with myeloproliferative neoplasms: ActivinA secretion by mesenchymal stromal cells correlates with the degree of marrow fibrosis","volume":"100","author":"Rambaldi","year":"2021","journal-title":"Ann. Hematol."},{"key":"ref_121","first-page":"999","article-title":"Bone mesenchymal stromal cells exhibit functional inhibition but no chromosomal aberrations in chronic myelogenous leukemia","volume":"17","author":"Xie","year":"2019","journal-title":"Oncol. Lett."},{"key":"ref_122","doi-asserted-by":"crossref","first-page":"1742","DOI":"10.1038\/leu.2014.97","article-title":"Functional and genetic aberrations of in vitro-cultured marrow-derived mesenchymal stromal cells of patients with classical Philadelphia-negative myeloproliferative neoplasms","volume":"28","author":"Avanzini","year":"2014","journal-title":"Leukemia"},{"key":"ref_123","doi-asserted-by":"crossref","first-page":"1884","DOI":"10.1016\/j.ejca.2011.11.003","article-title":"The characteristics and immunoregulatory functions of regulatory dendritic cells induced by mesenchymal stem cells derived from bone marrow of patient with chronic myeloid leukaemia","volume":"48","author":"Zhao","year":"2012","journal-title":"Eur. J. Cancer"},{"key":"ref_124","doi-asserted-by":"crossref","first-page":"3697","DOI":"10.1002\/jcp.27142","article-title":"Alteration of cellular and immune-related properties of bone marrow mesenchymal stem cells and macrophages by K562 chronic myeloid leukemia cell derived exosomes","volume":"234","author":"Jafarzadeh","year":"2019","journal-title":"J. Cell. Physiol."},{"key":"ref_125","doi-asserted-by":"crossref","unstructured":"Agarwal, P., Isringhausen, S., Li, H., Paterson, A.J., He, J., Gomariz, A., Nagasawa, T., Nombela-Arrieta, C., and Bhatia, R. (2019). Mesenchymal Niche-Specific Expression of Cxcl12 Controls Quiescence of Treatment-Resistant Leukemia Stem Cells. Cell Stem Cell, 24.","DOI":"10.1016\/j.stem.2019.02.018"},{"key":"ref_126","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.leukres.2017.07.007","article-title":"Bone marrow mesenchymal stromal cell (MSC) gene profiling in chronic myeloid leukemia (CML) patients at diagnosis and in deep molecular response induced by tyrosine kinase inhibitors (TKIs)","volume":"60","author":"Aggoune","year":"2017","journal-title":"Leuk. Res."},{"key":"ref_127","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/j.stem.2013.06.009","article-title":"Myeloproliferative neoplasia remodels the endosteal bone marrow niche into a self-reinforcing leukemic niche","volume":"13","author":"Schepers","year":"2013","journal-title":"Cell Stem Cell"},{"key":"ref_128","doi-asserted-by":"crossref","first-page":"1141610","DOI":"10.3389\/fonc.2023.1141610","article-title":"Mesenchymal stromal cells in tumor microenvironment remodeling of BCR-ABL negative myeloproliferative diseases","volume":"13","author":"Giallongo","year":"2023","journal-title":"Front. Oncol."},{"key":"ref_129","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1111\/bjh.13471","article-title":"Altered fibronectin expression and deposition by myeloproliferative neoplasm-derived mesenchymal stromal cells","volume":"172","author":"Abbonante","year":"2016","journal-title":"Br. J. Haematol."},{"key":"ref_130","doi-asserted-by":"crossref","first-page":"514","DOI":"10.3324\/haematol.2012.076752","article-title":"Involvement of TGFbeta1 in autocrine regulation of proplatelet formation in healthy subjects and patients with primary myelofibrosis","volume":"98","author":"Badalucco","year":"2013","journal-title":"Haematologica"},{"key":"ref_131","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1186\/s13045-014-0092-2","article-title":"Activated fibronectin-secretory phenotype of mesenchymal stromal cells in pre-fibrotic myeloproliferative neoplasms","volume":"7","author":"Schneider","year":"2014","journal-title":"J. Hematol. Oncol."},{"key":"ref_132","doi-asserted-by":"crossref","first-page":"986","DOI":"10.1182\/blood-2006-12-064626","article-title":"Pivotal contributions of megakaryocytes to the biology of idiopathic myelofibrosis","volume":"110","author":"Ciurea","year":"2007","journal-title":"Blood"},{"key":"ref_133","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1002\/ajh.25047","article-title":"The spleen of patients with myelofibrosis harbors defective mesenchymal stromal cells","volume":"93","author":"Avanzini","year":"2018","journal-title":"Am. J. Hematol."},{"key":"ref_134","doi-asserted-by":"crossref","first-page":"972","DOI":"10.1182\/blood-2014-12-618595","article-title":"Lipocalin produced by myelofibrosis cells affects the fate of both hematopoietic and marrow microenvironmental cells","volume":"126","author":"Lu","year":"2015","journal-title":"Blood"},{"key":"ref_135","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1007\/s00428-013-1434-0","article-title":"Platelet derived growth factor receptor-beta (PDGFRbeta) expression is limited to activated stromal cells in the bone marrow and shows a strong correlation with the grade of myelofibrosis","volume":"463","author":"Bedekovics","year":"2013","journal-title":"Virchows Arch."},{"key":"ref_136","doi-asserted-by":"crossref","first-page":"25055","DOI":"10.18632\/aging.203779","article-title":"IGFBP-6\/sonic hedgehog\/TLR4 signalling axis drives bone marrow fibrotic transformation in primary myelofibrosis","volume":"13","author":"Longhitano","year":"2021","journal-title":"Aging"},{"key":"ref_137","doi-asserted-by":"crossref","unstructured":"Schneider, R.K., Mullally, A., Dugourd, A., Peisker, F., Hoogenboezem, R., Van Strien, P.M.H., Bindels, E.M., Heckl, D., Busche, G., and Fleck, D. (2017). Gli1(+) Mesenchymal Stromal Cells Are a Key Driver of Bone Marrow Fibrosis and an Important Cellular Therapeutic Target. Cell Stem Cell, 20.","DOI":"10.1016\/j.stem.2017.03.008"},{"key":"ref_138","doi-asserted-by":"crossref","first-page":"3026","DOI":"10.1182\/blood-2008-06-158386","article-title":"Does primary myelofibrosis involve a defective stem cell niche? From concept to evidence","volume":"112","author":"Lataillade","year":"2008","journal-title":"Blood"},{"key":"ref_139","doi-asserted-by":"crossref","first-page":"4753","DOI":"10.1158\/0008-5472.CAN-14-3696","article-title":"Osteogenic Potential of Mesenchymal Stromal Cells Contributes to Primary Myelofibrosis","volume":"75","author":"Martinaud","year":"2015","journal-title":"Cancer Res."},{"key":"ref_140","doi-asserted-by":"crossref","unstructured":"Leimkuhler, N.B., Gleitz, H.F.E., Ronghui, L., Snoeren, I.A.M., Fuchs, S.N.R., Nagai, J.S., Banjanin, B., Lam, K.H., Vogl, T., and Kuppe, C. (2021). Heterogeneous bone-marrow stromal progenitors drive myelofibrosis via a druggable alarmin axis. Cell Stem Cell, 28.","DOI":"10.1016\/j.stem.2020.11.004"},{"key":"ref_141","doi-asserted-by":"crossref","first-page":"454","DOI":"10.3390\/hematolrep15030047","article-title":"How I Manage Chronic Lymphocytic Leukemia","volume":"15","author":"Nasnas","year":"2023","journal-title":"Hematol. Rep."},{"key":"ref_142","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1182\/blood-2007-05-092486","article-title":"Relevance of CD49d protein expression as overall survival and progressive disease prognosticator in chronic lymphocytic leukemia","volume":"111","author":"Gattei","year":"2008","journal-title":"Blood"},{"key":"ref_143","doi-asserted-by":"crossref","first-page":"3121","DOI":"10.1158\/0008-5472.CAN-08-4136","article-title":"Circulating B-cell chronic lymphocytic leukemia cells display impaired migration to lymph nodes and bone marrow","volume":"69","author":"Hartmann","year":"2009","journal-title":"Cancer Res."},{"key":"ref_144","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1111\/j.1365-2141.2009.07868.x","article-title":"Bi-directional activation between mesenchymal stem cells and CLL B-cells: Implication for CLL disease progression","volume":"147","author":"Ding","year":"2009","journal-title":"Br. J. Haematol."},{"key":"ref_145","doi-asserted-by":"crossref","first-page":"1594","DOI":"10.3324\/haematol.2016.163337","article-title":"Extracellular vesicles of bone marrow stromal cells rescue chronic lymphocytic leukemia B cells from apoptosis, enhance their migration and induce gene expression modifications","volume":"102","author":"Crompot","year":"2017","journal-title":"Haematologica"},{"key":"ref_146","doi-asserted-by":"crossref","first-page":"1106","DOI":"10.1182\/blood-2014-12-618025","article-title":"Exosomes released by chronic lymphocytic leukemia cells induce the transition of stromal cells into cancer-associated fibroblasts","volume":"126","author":"Paggetti","year":"2015","journal-title":"Blood"},{"key":"ref_147","doi-asserted-by":"crossref","first-page":"1692","DOI":"10.1158\/1541-7786.MCR-17-0026","article-title":"B-cell Receptor Signaling Regulates Metabolism in Chronic Lymphocytic Leukemia","volume":"15","author":"Vangapandu","year":"2017","journal-title":"Mol. Cancer Res."},{"key":"ref_148","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1002\/stem.3352","article-title":"Protein kinase C-beta-dependent changes in the glucose metabolism of bone marrow stromal cells of chronic lymphocytic leukemia","volume":"39","author":"Fuchs","year":"2021","journal-title":"Stem Cells"},{"key":"ref_149","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1016\/j.neo.2017.07.004","article-title":"The Stromal Microenvironment Modulates Mitochondrial Oxidative Phosphorylation in Chronic Lymphocytic Leukemia Cells","volume":"19","author":"Vangapandu","year":"2017","journal-title":"Neoplasia"},{"key":"ref_150","doi-asserted-by":"crossref","first-page":"2984","DOI":"10.1182\/blood-2010-02-269894","article-title":"Platelet-derived growth factor (PDGF)-PDGF receptor interaction activates bone marrow-derived mesenchymal stromal cells derived from chronic lymphocytic leukemia: Implications for an angiogenic switch","volume":"116","author":"Ding","year":"2010","journal-title":"Blood"},{"key":"ref_151","doi-asserted-by":"crossref","first-page":"1414","DOI":"10.1038\/sj.leu.2401825","article-title":"Increased bone marrow angiogenesis in B cell chronic lymphocytic leukemia","volume":"14","author":"Kini","year":"2000","journal-title":"Leukemia"},{"key":"ref_152","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1038\/ncb2432","article-title":"Stromal control of cystine metabolism promotes cancer cell survival in chronic lymphocytic leukaemia","volume":"14","author":"Zhang","year":"2012","journal-title":"Nat. Cell Biol."},{"key":"ref_153","doi-asserted-by":"crossref","first-page":"5573","DOI":"10.1182\/blood-2011-01-270140","article-title":"Monoclonal gammopathy of undetermined significance (MGUS) and smoldering multiple myeloma (SMM): Novel biological insights and development of early treatment strategies","volume":"117","author":"Korde","year":"2011","journal-title":"Blood"},{"key":"ref_154","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1111\/imr.12233","article-title":"Targeting the bone marrow microenvironment in multiple myeloma","volume":"263","author":"Kawano","year":"2015","journal-title":"Immunol. Rev."},{"key":"ref_155","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/j.soncn.2017.05.012","article-title":"Pathobiology and Diagnosis of Multiple Myeloma","volume":"33","author":"Brigle","year":"2017","journal-title":"Semin. Oncol. Nurs."},{"key":"ref_156","doi-asserted-by":"crossref","unstructured":"Rasch, S., Lund, T., Asmussen, J.T., Lerberg Nielsen, A., Faebo Larsen, R., Osterheden Andersen, M., and Abildgaard, N. (2020). Multiple Myeloma Associated Bone Disease. Cancers, 12.","DOI":"10.20944\/preprints202007.0041.v1"},{"key":"ref_157","doi-asserted-by":"crossref","first-page":"986","DOI":"10.1634\/stemcells.2005-0220","article-title":"A crosstalk between myeloma cells and marrow stromal cells stimulates production of DKK1 and interleukin-6: A potential role in the development of lytic bone disease and tumor progression in multiple myeloma","volume":"24","author":"Gunn","year":"2006","journal-title":"Stem Cells"},{"key":"ref_158","doi-asserted-by":"crossref","first-page":"2183","DOI":"10.1158\/0008-5472.CAN-11-2067","article-title":"Bone marrow stromal cells create a permissive microenvironment for myeloma development: A new stromal role for Wnt inhibitor Dkk1","volume":"72","author":"Fowler","year":"2012","journal-title":"Cancer Res."},{"key":"ref_159","doi-asserted-by":"crossref","first-page":"322","DOI":"10.4252\/wjsc.v6.i3.322","article-title":"Multiple myeloma mesenchymal stromal cells: Contribution to myeloma bone disease and therapeutics","volume":"6","author":"Garayoa","year":"2014","journal-title":"World J. Stem Cells"},{"key":"ref_160","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.exphem.2009.11.009","article-title":"Distinct transcriptional profiles characterize bone microenvironment mesenchymal cells rather than osteoblasts in relationship with multiple myeloma bone disease","volume":"38","author":"Todoerti","year":"2010","journal-title":"Exp. Hematol."},{"key":"ref_161","doi-asserted-by":"crossref","first-page":"2913","DOI":"10.1158\/1078-0432.CCR-17-2627","article-title":"The Pattern of Mesenchymal Stem Cell Expression Is an Independent Marker of Outcome in Multiple Myeloma","volume":"24","author":"Schinke","year":"2018","journal-title":"Clin. Cancer Res."},{"key":"ref_162","doi-asserted-by":"crossref","first-page":"1056","DOI":"10.1038\/s41598-018-38314-8","article-title":"Transcriptome Analysis of Mesenchymal Stem Cells from Multiple Myeloma Patients Reveals Downregulation of Genes Involved in Cell Cycle Progression, Immune Response, and Bone Metabolism","volume":"9","author":"Fernando","year":"2019","journal-title":"Sci. Rep."},{"key":"ref_163","doi-asserted-by":"crossref","unstructured":"Lemaitre, L., DoSouto Ferreira, L., Joubert, M.V., Avet-Loiseau, H., Martinet, L., Corre, J., and Couderc, B. (2020). Imprinting of Mesenchymal Stromal Cell Transcriptome Persists even after Treatment in Patients with Multiple Myeloma. Int. J. Mol. Sci., 21.","DOI":"10.3390\/ijms21113854"},{"key":"ref_164","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1038\/s41590-021-00931-3","article-title":"The multiple myeloma microenvironment is defined by an inflammatory stromal cell landscape","volume":"22","author":"Kellermayer","year":"2021","journal-title":"Nat. Immunol."},{"key":"ref_165","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1038\/s41419-018-0545-6","article-title":"Dicer1 downregulation by multiple myeloma cells promotes the senescence and tumor-supporting capacity and decreases the differentiation potential of mesenchymal stem cells","volume":"9","author":"Guo","year":"2018","journal-title":"Cell Death Dis."},{"key":"ref_166","doi-asserted-by":"crossref","unstructured":"Andre, T., Meuleman, N., Stamatopoulos, B., De Bruyn, C., Pieters, K., Bron, D., and Lagneaux, L. (2013). Evidences of early senescence in multiple myeloma bone marrow mesenchymal stromal cells. PLoS ONE, 8.","DOI":"10.1371\/journal.pone.0059756"},{"key":"ref_167","first-page":"192","article-title":"Inhibitory effects of osteoblasts and increased bone formation on myeloma in novel culture systems and a myelomatous mouse model","volume":"91","author":"Yaccoby","year":"2006","journal-title":"Haematologica"},{"key":"ref_168","doi-asserted-by":"crossref","first-page":"111213","DOI":"10.18632\/oncotarget.22740","article-title":"Alteration of mitochondrial biogenesis promotes disease progression in multiple myeloma","volume":"8","author":"Zhan","year":"2017","journal-title":"Oncotarget"},{"key":"ref_169","doi-asserted-by":"crossref","unstructured":"Romano, A., Conticello, C., Cavalli, M., Vetro, C., La Fauci, A., Parrinello, N.L., and Di Raimondo, F. (2014). Immunological dysregulation in multiple myeloma microenvironment. Biomed. Res. Int., 2014.","DOI":"10.1155\/2014\/198539"},{"key":"ref_170","doi-asserted-by":"crossref","first-page":"85764","DOI":"10.18632\/oncotarget.7969","article-title":"Granulocyte-like myeloid derived suppressor cells (G-MDSC) are increased in multiple myeloma and are driven by dysfunctional mesenchymal stem cells (MSC)","volume":"7","author":"Giallongo","year":"2016","journal-title":"Oncotarget"},{"key":"ref_171","doi-asserted-by":"crossref","first-page":"858","DOI":"10.1080\/15384101.2018.1442624","article-title":"Bone marrow-derived mesenchymal stem cells promote cell proliferation of multiple myeloma through inhibiting T cell immune responses via PD-1\/PD-L1 pathway","volume":"17","author":"Chen","year":"2018","journal-title":"Cell Cycle"},{"key":"ref_172","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1111\/cei.13594","article-title":"Bone marrow-derived mesenchymal stem cells inhibit CD8(+) T cell immune responses via PD-1\/PD-L1 pathway in multiple myeloma","volume":"205","author":"Liu","year":"2021","journal-title":"Clin. Exp. Immunol."},{"key":"ref_173","doi-asserted-by":"crossref","first-page":"e861","DOI":"10.1002\/ctm2.861","article-title":"CD155\/TIGIT signalling plays a vital role in the regulation of bone marrow mesenchymal stem cell-induced natural killer-cell exhaustion in multiple myeloma","volume":"12","author":"Liu","year":"2022","journal-title":"Clin. Transl. Med."},{"key":"ref_174","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1007\/s10555-022-10069-9","article-title":"Mesenchymal stromal cell senescence in haematological malignancies","volume":"42","author":"Plakhova","year":"2023","journal-title":"Cancer Metastasis Rev."},{"key":"ref_175","doi-asserted-by":"crossref","first-page":"2449","DOI":"10.1158\/0008-5472.CAN-17-3115","article-title":"From MGUS to Multiple Myeloma, a Paradigm for Clonal Evolution of Premalignant Cells","volume":"78","author":"Spaan","year":"2018","journal-title":"Cancer Res."},{"key":"ref_176","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1002\/sctm.18-0070","article-title":"Commitment to Aerobic Glycolysis Sustains Immunosuppression of Human Mesenchymal Stem Cells","volume":"8","author":"Liu","year":"2019","journal-title":"Stem Cells Transl. Med."},{"key":"ref_177","doi-asserted-by":"crossref","first-page":"2285","DOI":"10.1158\/0008-5472.CAN-18-0773","article-title":"CD38-Driven Mitochondrial Trafficking Promotes Bioenergetic Plasticity in Multiple Myeloma","volume":"79","author":"Marlein","year":"2019","journal-title":"Cancer Res."},{"key":"ref_178","doi-asserted-by":"crossref","unstructured":"Matula, Z., Mikala, G., Lukacsi, S., Matko, J., Kovacs, T., Monostori, E., Uher, F., and Valyi-Nagy, I. (2021). Stromal Cells Serve Drug Resistance for Multiple Myeloma via Mitochondrial Transfer: A Study on Primary Myeloma and Stromal Cells. Cancers, 13.","DOI":"10.3390\/cancers13143461"},{"key":"ref_179","doi-asserted-by":"crossref","unstructured":"Matula, Z., Uher, F., Valyi-Nagy, I., and Mikala, G. (2023). The Effect of Belantamab Mafodotin on Primary Myeloma-Stroma Co-Cultures: Asymmetrical Mitochondrial Transfer between Myeloma Cells and Autologous Bone Marrow Stromal Cells. Int. J. Mol. Sci., 24.","DOI":"10.3390\/ijms24065303"},{"key":"ref_180","doi-asserted-by":"crossref","first-page":"e13388","DOI":"10.1111\/cpr.13388","article-title":"Lactate trafficking inhibition restores sensitivity to proteasome inhibitors and orchestrates immuno-microenvironment in multiple myeloma","volume":"56","author":"Barbato","year":"2023","journal-title":"Cell Prolif."},{"key":"ref_181","doi-asserted-by":"crossref","first-page":"604143","DOI":"10.3389\/fonc.2020.604143","article-title":"Mitochondrial Bioenergetics at the Onset of Drug Resistance in Hematological Malignancies: An Overview","volume":"10","author":"Barbato","year":"2020","journal-title":"Front. Oncol."},{"key":"ref_182","doi-asserted-by":"crossref","first-page":"415024","DOI":"10.1155\/2015\/415024","article-title":"Inflammation as a Keystone of Bone Marrow Stroma Alterations in Primary Myelofibrosis","volume":"2015","author":"Desterke","year":"2015","journal-title":"Mediat. Inflamm."},{"key":"ref_183","doi-asserted-by":"crossref","first-page":"4341","DOI":"10.1182\/blood-2008-10-186668","article-title":"CXCR4 inhibitor AMD3100 disrupts the interaction of multiple myeloma cells with the bone marrow microenvironment and enhances their sensitivity to therapy","volume":"113","author":"Azab","year":"2009","journal-title":"Blood"},{"key":"ref_184","doi-asserted-by":"crossref","first-page":"1672","DOI":"10.3389\/fonc.2020.01672","article-title":"Targeting CXCR4 in AML and ALL","volume":"10","author":"Cancilla","year":"2020","journal-title":"Front. Oncol."},{"key":"ref_185","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.3324\/haematol.2010.029736","article-title":"An interaction between hepatocyte growth factor and its receptor (c-MET) prolongs the survival of chronic lymphocytic leukemic cells through STAT3 phosphorylation: A potential role of mesenchymal cells in the disease","volume":"96","author":"Giannoni","year":"2011","journal-title":"Haematologica"},{"key":"ref_186","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1016\/j.ijrobp.2017.02.216","article-title":"Inhibition of Bcl-2\/xl With ABT-263 Selectively Kills Senescent Type II Pneumocytes and Reverses Persistent Pulmonary Fibrosis Induced by Ionizing Radiation in Mice","volume":"99","author":"Pan","year":"2017","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"ref_187","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1182\/bloodadvances.2022007033","article-title":"p16INK4A-dependent senescence in the bone marrow niche drives age-related metabolic changes of hematopoietic progenitors","volume":"7","author":"Hellmich","year":"2023","journal-title":"Blood Adv."}],"container-title":["Biomolecules"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2218-273X\/13\/12\/1701\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T21:29:00Z","timestamp":1760131740000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2218-273X\/13\/12\/1701"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,11,24]]},"references-count":187,"journal-issue":{"issue":"12","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["biom13121701"],"URL":"https:\/\/doi.org\/10.3390\/biom13121701","relation":{},"ISSN":["2218-273X"],"issn-type":[{"value":"2218-273X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,11,24]]}}}